ArticleNature communications2026
Weighted sliced inverse regression for scalable supervised dimensionality reduction of spatial transcriptomics data.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
With the rise of spatially resolved transcriptomics biotechnologies, performing spatially-aware analysis of the resulting data is crucial to maximise advances in biological understanding. Dimensionality reduction is a first step in most analyses of spatial transcriptomics data, and common approaches that preserve total variation of gene expression features do not usually preserve biologically meaningful spatial variation. To this end, we develop weighted sliced inverse regression (wSIR), a sufficient dimension reduction technique that aims to retain the predictive power of the spatial coordinates. wSIR is applicable to multiple distinct spatial transcriptomic datasets and is highly scalable, with over 100, 000 cells processed in under two minutes on a standard laptop. The feature loadings are interpretable, and new non-spatial data can be projected into wSIR's low-dimensional space for downstream analyses. We examine wSIR's performance and demonstrate its biological relevance through two case studies in human breast cancer and mouse early embryonic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.